Dr. Pawluczyk is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1520 San Pablo St
Ste 1652
Los Angeles, CA 90033Phone+1 323-442-6000Fax+1 323-442-6001
Education & Training
- University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Psychiatry, 1984 - 1993
- University of Buenos AiresClass of 1973
Certifications & Licensure
- CA State Medical License 1986 - 2026
Publications & Presentations
PubMed
- 39 citationsHigher CSF sTREM2 attenuates ApoE4-related risk for cognitive decline and neurodegenerationNicolai Franzmeier, M. Suárez-Calvet, Lukas Frontzkowski, Annah M. Moore, Timothy J. Hohman
Molecular Neurodegeneration. 2020-10-08 - 22 citationsSafety, tolerability, and pharmacokinetics of allopregnanolone as a regenerative therapeutic for Alzheimer's disease: A single and multiple ascending dose phase 1b/2a ...Gerson D. Hernandez, Christine M. Solinsky, Wendy J. Mack, Naoko Kono, Kathleen E. Rodgers
Alzheimer's & Dementia. 2020-01-01 - 25 citationsEscitalopram for agitation in Alzheimer's disease (S-CitAD): Methods and design of an investigator-initiated, randomized, controlled, multicenter clinical trial.Stephan Ehrhardt, Anton P. Porsteinsson, Cynthia A. Munro, Paul B. Rosenberg, Bruce G. Pollock
Alzheimer's & Dementia. 2019-10-03
Press Mentions
- Associations of Regional Brain Structural Differences with Aging, Modifiable Risk Factors for Dementia, and Cognitive PerformanceDecember 2nd, 2019
- Association of Altered Liver Enzymes with AD, Cognition, Neuroimaging Measures, and Cerebrospinal Fluid BiomarkersJuly 31st, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: